⏱ GENERATED 12/11/2025
This report was generated once, at the time listed.
▼ NO MICRO CONTRACTS
Contracts or transactions under $2,000 are not included.
🚫 NOT OFFICIAL
Meter uses government data, but isn't an official source.
The vendors that received the most money from Office of Assistant Secretary for Preparedness and Response in September 2025, across all contracts awarded that month.
The most-awarded NAICS codes from Office of Assistant Secretary for Preparedness and Response in September 2025, across all awarded contracts.
Important phrases and terms that appear significantly more in Office of Assistant Secretary for Preparedness and Response contracts during September 2025 compared to government-wide patterns.
The highest-value individual contract awards from Office of Assistant Secretary for Preparedness and Response in September 2025.
$58,051,983
SAN DIEGO, CALIFORNIA
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; R&D ADMINISTRATIVE EXPENSES | AN14
DEVELOPMENT OF CD388 AS A LONG-LASTING PROPHYLACTIC ANTI-VIRAL OPTION FOR PROTECTION AGAINST THE HEALTH IMPACTS CAUSED BY INFLUENZA
BARDA - ASPR / DAAPPO / BARDA DCMA
Sep 30, 2025
9/30/25 → 9/29/27
$56,000,000
GAITHERSBURG, MARYLAND
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 325414
MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | 6515
ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)
ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)
ASPR/ORM-SNS
25.1: Advisory and assistance services;25.2: Other services from non-Federal sources;26.0: Supplies and materials
0001: ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE;0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND;0801: REIMBURSABLE PROGRAM (FEMA)
Sep 5, 2025
8/30/19 → 8/29/29
$47,794,830
TULSA, OKLAHOMA
PHARMACEUTICAL PREPARATION MANUFACTURING | 325412
DRUGS AND BIOLOGICALS | 6505
AMOXICILLIN TRIHYDRATE 500 MG ORAL CAPSULES 60 AND 100 COUNT BOTTLES
ASPR/ORM-SNS
Sep 27, 2025
9/30/25 → 9/29/27
$45,623,186
SAINT LOUIS, MISSOURI
PHARMACEUTICAL PREPARATION MANUFACTURING | 325412
CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY | 3650
ATROPINE & PRALIDOXIME CHLORIDE INJECTOR, SINGLE DOSE AUTO-INJECTORS
ASPR/ORM-SNS
26.0: Supplies and materials
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Sep 18, 2025
9/30/24 → 9/29/26
$37,485,000
SOUTH SAN FRANCISCO, CALIFORNIA
ADMINISTRATIVE MANAGEMENT AND GENERAL MANAGEMENT CONSULTING SERVICES | 541611
DRUGS AND BIOLOGICALS | 6505
PROCURENT OF XOFLUZA (BALOXAVIR MARBOXIL) 40MG AND 80MG TABLETS
ASPR/ORM-SNS
Sep 26, 2025
9/26/25 → 9/29/27
$36,255,005
LAKE ZURICH, ILLINOIS
PHARMACEUTICAL PREPARATION MANUFACTURING | 325412
DRUGS AND BIOLOGICALS | 6505
BULK PHARMA - GROUP B (ASSET MGMT) ACYCLOVIR SODIUM SOLUTION, DOXYCYCLINE INJ., MEROPENEM, SODIUM CHLORIDE, STERILE WATER
BARDA - ASPR / DAAPPO / BARDA DCMA
26.0: Supplies and materials
0001: ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Sep 11, 2025
3/14/25 → 3/13/30
$24,873,330
SWIFTWATER, PENNSYLVANIA
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | AN12
TO CONDUCT A CLINICAL TRIAL TO ASSESS THE SAFETY, IMMUNOGENICITY, ANTIGEN DOSE, OF MATRIX-M ADJUVANT IN COMBINATION WITH U.S. DOMESTICALLY MANUFACTURED, EGG-BASED A/ASTRAKHAN/3212/2020 (H5N8) INFLUENZA VIRUS VACCINE IN HEALTHY ADULTS AND OLDER ADULTS
BARDA - ASPR / DAAPPO / BARDA DCMA
Sep 8, 2025
9/5/25 → 9/4/28
$24,706,190
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH | AN42
THE DEVELOPMENT OF ANTIMICROBIALS FOR THE TREATMENT OF RESISTANT FUNGAL AND BACTERIAL INFECTIONS - OTA
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE
Sep 15, 2025
9/30/24 → 9/30/31
$20,946,417
PHARMACEUTICAL PREPARATION MANUFACTURING | 325412
DRUGS AND BIOLOGICALS | 6505
RAFA ATROPINE AUTO-INJECTORS (0.5 MG, 1 MG, AND 2 MG)
ASPR/ORM-SNS
Sep 30, 2025
9/30/25 → 9/29/26
$20,000,000
CHICAGO, ILLINOIS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
AOI #23+: HOST-BASED DIAGNOSTICS - EXPANSION OF IMMUNIX PLATFORM FOR PRECISION MEDICINE IN SEVERE ACUTE RESPIRATORY INFECTIONS AND ARDS
BARDA - ASPR / DAAPPO / BARDA DCMA
Sep 29, 2025
9/30/25 → 8/1/29
The largest contract de-obligations (spending reductions or cancellations) from Office of Assistant Secretary for Preparedness and Response in September 2025.
-$15,612,000
SOUTH SAN FRANCISCO, CALIFORNIA
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 541714
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
HIGH THROUGHPUT SARS-COV-2 NEUTRALIZING ANTIBODY IMMUNOASSAY FOR QUALIFYING VARIANTS AND TESTING OF HUMAN SERUM SAMPLES.
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Sep 15, 2025
11/29/21 → 11/28/25
-$2,050,557
SAN DIEGO, CALIFORNIA
RESEARCH AND DEVELOPMENT IN THE SOCIAL SCIENCES AND HUMANITIES | 541720
HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | AN12
MAPP EAP - IGF::CL::IGF FOR OTHER FUNCTIONSEXPANDED ACCESS PROTOCOL FOR ZMAPP
EXPANDED ACCESS PROTOCOL FOR ZMAPP
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Sep 4, 2025
6/27/16 → 12/31/27
-$1,522,422
DURHAM, NORTH CAROLINA
BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 325414
DRUGS AND BIOLOGICALS | 6505
STORAGE AND STABILITY OF INFLUENZA VACCINE STOCKPILE
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services;25.2: Other services from non-Federal sources
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Sep 30, 2025
6/21/19 → 2/21/22
-$1,484,637
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | 541711
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
IGF::CT::IGF ATOX
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Sep 8, 2025
9/30/14 → 12/31/20
-$1,234,383
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY | 541711
HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | AN13
IGF::OT::IGF
INNOVATIVE TREATMENTSFOR MULTIDRUG RESISTANT INFECTIONS
BARDA - ASPR / DAAPPO / BARDA DCMA
25.1: Advisory and assistance services
0001: PUBLIC HEALTH AND SOCIAL SERVICES EMERGENCY FUND
Sep 17, 2025
9/15/15 → 9/30/25
The top locations where contract work for Office of Assistant Secretary for Preparedness and Response in September 2025 is performed.
13 contracts
7 contracts
13 contracts
6 contracts
1 contracts
11 contracts
1 contracts
50 contracts
5 contracts
8 contracts
13 contracts
2 contracts
1 contracts
1 contracts
1 contracts
50 contracts
1 contracts
3 contracts
6 contracts
3 contracts
The top locations where vendors receiving awards from Office of Assistant Secretary for Preparedness and Response in September 2025 list as their primary business address.
8 contracts
9 contracts
36 contracts
8 contracts
15 contracts
2 contracts
1 contracts
1 contracts
1 contracts
5 contracts
The congressional districts where contract work for Office of Assistant Secretary for Preparedness and Response in September 2025 will be performed.